Robohub.org
SCHAFT staying in DRC | Automaton
After the DARPA Robotics Challenge Trials ended last December and Team SCHAFT emerged victorious, there was a rumor going around that Google, which had acquired SCHAFT just months earlier, wasn’t going to allow the team to remain in the competition. Some observers speculated that Google was apparently reluctant to accept funding from DARPA and establish ties with the U.S. military (DARPA is an agency of the Department of Defense). Today, DARPA announced that, contrary to the rumor, SCHAFT is staying in the DRC.
Read more by Evan Ackerman and Erico Guizzo on Automaton.
tags: DARPA, DRC
Robohub Editors
Related posts :
Touch sensing: An important tool for mobile robot navigation
Proximal sensing often is a blind spot for most long range sensors such as cameras and lidars for which touch sensors could serve as a complementary modality.
29 November 2022, by
Kshitij Tiwari
Study: Automation drives income inequality
New data suggest most of the growth in the wage gap since 1980 comes from automation displacing less-educated workers.
27 November 2022, by
MIT News
Flocks of assembler robots show potential for making larger structures
Researchers make progress toward groups of robots that could build almost anything, including buildings, vehicles, and even bigger robots.
25 November 2022, by
MIT News
Holiday robot wishlist for/from Women in Robotics
Are you looking for a gift for the women in robotics in your life? Or the up and coming women in robotics in your family? Perhaps these suggestions from our not-for-profit Women in Robotics organization will inspire!
24 November 2022, by
Women In Robotics and Andra Keay
TRINITY, the European network for Agile Manufacturing
The Trinity project is the magnet that connects every segment of agile with everyone involved, creating a network that supports people, organisations, production and processes.
20 November 2022, by
RI4EU
Fighting tumours with magnetic bacteria
Researchers at ETH Zurich are planning to use magnetic bacteria to fight cancerous tumours. They have now found a way for these microorganisms to effectively cross blood vessel walls and subsequently colonise a tumour.
19 November 2022, by
ETH Zurich